ARCHIVES

Bypass Budget Will Call For 15-percent Increase

This article is from The Cancer Letter archive.

Vol. 37 No. 07 | February 18, 2011

Download PDF Visit The Full Archive

Related Articles

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

NIH Revitalization Act Authorizes $3 Billion For NCI In FY97

July 5, 1996

FDA Approves Medication For Smoking Cessation

May 26, 2006

OD Contract Concepts Okayed

October 17, 1986

NIH Scientists Engineer Mice That Get Burkitt’s Lymphoma.

October 20, 2000

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996